Member Info for undersold

They're annoyed that you keep wiping their deramping from the latest 5 comments, which is all casuals see at the bottom of https://www.lse.co.uk/SharePrice.html?shareprice=QED

Keep it up. You make this board toxic for shorting investment fund trolls who want to set the narritive.

Https://find-and-update.company-information.service.gov.uk/company/06374598/filing-history

Looks to principally lay out credit hirearchy. IMO the company is preparing for liquidation.

Goodbye money

What are your thoughts on the 590,000,000 shares being admitted to the market tomorrow with no lock-up period?

The (patient run and somewhat speculative) site Medbud is claiming Celadon's medical flower will finally go on sale in the UK this Monday, the 19th of August.

https://medbud.wiki/producers/celadon-pharmaceuticals/

If the medicine is priced as claimed at £13/g, this is at or near the highest market price for these products. I -think- Initial batches are, or are limited to 10kg? This would mean a possinle £250k gross sales?

IMO the real value is the pass this gives to the rest of the crop, which in future can be shipped in larger batches to keep up with the prescription orderbook

Prescription medicine in the UK is tax free, and as a domestic supplier, Celadon doesn't have import costs or checks to deal with.

I inferred a lot of info from these supplier guidance documents: https://www.gov.uk/government/publications/supply-unlicensed-medicinal-products-specials

IMO being one of the first few domestic suppliers to a growing tax-free market like this is HUGE, great things lie ahead if we can solve this cashflow problem

It looks like there's some sort of exclusivity agreement with one of the pharmacies? Hopefully this perk paid upfront :)

GLA

So presumably the new loan was intended to advance the state of the site, increasing the value of the business.

But HELD seized defeat from the jaws of victory by announcing -prior to receipt- they would instead use it to pay off a prior loan?

And the new creditors got cold feet?

Dav, how are you paying Riverfort now, with no new loan & no ability to pay via new shares with the instrument suspended?

Did the board already have a firm 'no' from the new creditors by mid-June?

Is this why the non-exec chair stood down?

IMO there's now a real possibility the only thing that will ever grow at HELD is empty bags.

For those who can't read past the saltposters, we're waiting for news on this £1m loan + cultivation update.

Why the silence from the Hellenic Dynamics?

I clock at least two 'Investor calls' that weren't transcribed and published.

If we don't get an update by Monday, it paints a very dire picture imo.

On a positive note: the area where HD are based ( https://maps.app.goo.gl/1aPYrePMeJnJkxJt7 ) is not prone to wildfire, underground bunkers even less so.

If only we could lure Dav & the board out from theirs.

IMO anyone selling at these prices is daft, there's supposed to be a £1m loan coming in this week.

I did write about this a few days ago, but any time a positive post is made, it gets pushed down by doom and gloom.

In Greece, medical cannabis is illegal to import and can only be domestically produced. Greece only issued its first prescription Feb 17th this year.

Following this, HELD switched tracks to target the now-open Greek domestic market, which has higher wholesale prices of €16.50/g:

https://www.linkedin.com/posts/hellenic-dynamics_greece-medicalcannabis-patientcare-activity-7196442306525224962-Qxnp/

HELD have a €1m 3.5% loan paying out in the next few weeks, likely based on the validity of that business plan:

https://www.lse.co.uk/rns/HELD/long-term-loan-agreement-f3vklkfkhz9o1ej.html

I remain confident that HELD is well placed for success.

Screeching every time the SP drops is noise, not research.

If any of you actually own stock in this company, you are doing your own positions harm.

Past noon and no trades. I guess tumbleweed is better than 1.49?

Not that it will be long before we see >1.5p, if we have to wait for the (Jul 31st?) annual report for real updates.

Maybe Davinder forgot to post April's investor call as a RNS? Surely HELD -have- to disclose information from investor calls?

If the stuff we saw in twitter screenshots (https://twitter.com/Blowster85/status/1775431672034394224 ) was shared properly by HELD then maybe we'd be looking at much higher SP.

That is, assuming any of it is true enough to put is writing.

I'm hoping IG is right & this is the bottom, have finally managed to average down to 3p on this dip :)

If 'no more dilution' were a stock, i'd short it.

Next excuse is mergers and acquisitions :)

*my general sentiment, not an opinion about HELD.

'of the 10,850,000 Placing Shares in respect of the Placing. It is expected that the Placing Shares will be admitted to trading and dealings will commence on the LSE on or around 14 May 2024 ("Admission"). '

https://www.lse.co.uk/rns/HELD/placing-issue-of-equity-1p7ra29qt2q8014.html

Today is the 16th, and the ask price has dropped to 2p.

I guess that means the shares were added to market this morning...

and we now have a 10m sellwall to push through before we can see a higher SP again?

I'm no pro/level2 investor though, this is just conjecture without access to the order book.

I remain optimistic about HELD.

I'm long, unil they post revenues at least, so this is another opportunity to average down before that.

I initially bought it at around 8p (post-RS price), but started last month at 3.9p, now down to 3.39 and going lower.

I understand frustration with the low SP, but it has been trending down since the IPO.

IMO anyone expecting long-term trend reversal prior to first revenues has made a very poor investment.

That isn't on anyone who is holding, it's on market makers who lower the bid/ask whenever the trades dry up.

As I understand it from the October '23 RNS: The Agricultural Research Ministry 'Elgo Dimitra' are growing unique mother plants for Hellenic Dynamics' initial strain library, which will likely be used to offer POD clients live clones?

Cross-breeding strains and picking likely mother plants is easy, but stabilising those traits to seed so you can grow a backup if the mother dies, is hard.

After stabilizing the traits, multiple harvests are needed to confirm potency before commercial production. Even if they're meeting the most optimistic targets possible, the people overseeing this process are the government, who probably demand exclusive right of access to parts of the site they occupy & refuse to give an update before the new strains are licensed and legally protected.

I don't think 6 months is enough time to develop new strains from seed to licensed crop, but it is possible they have the strains stabilised now, and have been able to show a strain catalogue to their new investor.

That HELD got this amazing 1m financing deal at least implies someone with deep pockets has seen behind the curtain, approved, and put their money where their mouth is.

This is all pure speculation on my part, but HELD seems to be progressing smoothly now. I don't get why anyone is selling.

As discussed in the investor call screenshots,( https://fxtwitter.com/Blowster85/status/1775431672034394224?s=20 ) HELD's advantage is that Greece doesn't allow cannabis imports, which -should- mean HELD can get better than market prices renting their first PODs out to the Greek domestic market.

This is likely why they got the sweet loan deal. Nothing to do with Germany, the US, or whatever our new ramper friends are on about.

Maybe peope are moving their money to US stocks?

I am, but not taking the loss i'd need to here.

You can't mortgage a building site

When the company entered the market through SPAC merger, shares in the SPAC were locked up for 12 months, ending 5th December 2023.

The SPAC investors bought in at 3p a share, and it looks to me like any time the price hits 4p they buy the orderbook back down to 3.0-3.3p

and it looks like what's left of the SPAC has deficient filing at companies house, so maybe they have no choice but to sell.

Speaking as a Brit, in my personal opinion:

I don't think many British patients or doctors would be willing to use OBD's tests if Nigel Farage were the one selling them.

Still, involving him might not be a total waste. A test warning Brits they're at risk of associating with Farage would absolutely fly off the shelves.

On a more serious note:

Private healthcare providers in the UK have to record events on NHS patient records, just like NHS providers do. Our National Health Service, via the NDRS Cancer Registry, is likely tracking use of OBD's tests in its routine data collection from NHS patient records, potentially as N:1 (single patient) trials. If testing improves real-world patient outcomes, this should inform further study by our regulators, and lead to an NHS-backed trial.

In contrast:

A pre-market test cohort big and varied enough to pass regulatory thresholds might have required additional financing, potentially dilutive to equity holders, or delayed launch long enough that OBD were beaten to market. I believe this soft launch is a deliberate strategy, and on balance, it's a reasonable approach.

Sadly, the core issue for me isn't the results themselves.

I don't trust OBD's CEO anymore, so recent hires that share history with him aren't the confidence boost they otherwise should be. Maybe after a full quarter with a sales manager, spring will show some meaningful revenue?

I'd settle for a path to profit backed by non-dilutive finance, but if we're expected to pick up the bill for being misled, it will take replacing Diggle to restore my confidence.

I'm holding, but this was only a punt for me. Not sure I'd trust them with a meaningful amount of my money.

I expect real upwards movement when they sell the first retail crop, but what is growing now seems to be government grown regulatory batches, which are a good sign, but probably an expense, not an asset.

With all the best will in the world, 6-7p based on what?

As I understand it, revenue isn't predicted for at least 6 months.